Pay to Marwadi

Company Profile

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private
BSE1079.555.15 (+0.48 % )
PREV CLOSE (Rs.) 1074.40
OPEN PRICE (Rs.) 1078.65
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 15310
TODAY'S LOW / HIGH (Rs.)1063.35 1085.15
52 WK LOW / HIGH (Rs.)1063.35 1888.05
NSE1078.60 1.1 (+0.1 % )
PREV CLOSE(Rs.) 1077.50
OPEN PRICE (Rs.) 1077.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1078.60 (10 )
VOLUME 98429
TODAY'S LOW / HIGH(Rs.) 1061.35 1089.40
52 WK LOW / HIGH (Rs.)1061.35 1887.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.19
TTM EPS (Rs.) 15.93
P/E Ratio 67.78
Book Value (Rs.) 308.28
Face Value (Rs.) 10
MCap (Rs. in Mn) 25252.89
Price/Earning (TTM) 42.69
Price/Sales (TTM) 6.25
Price/Book (MRQ) 3.50
PAT Margin (%) 10.01
ROCE (%) 7.49
Incorporation Year : 1996

Management Info :

Chintan Nitinkumar Shah - Chairman Chintan Nitinkumar Shah - Managing Director

Registered Office :

Address : Plot No 502/17,G I D C Estate,Ankleshwar,
Bharuch,
Gujarat-393002

Phone : 07574848533 / 34

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
16Mar03-16-2024$Tatva Chintan Pharma Chem submits analyst meet intimation Tatva Chintan Pharma Chem su
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has submitted schedule of investor meeting that the Company would be participating. Date: 21 March 2024. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com.

The above information is a part of company’s filings submitted to BSE. 

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
27Jan01-27-2024$Tatva Chintan Pharma Chem informs about update Tatva Chintan Pharma Chem in
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Tatva Chintan Pharma Chem has informed that it has revamped its website, www.tatvachintan.com, which is more user and Investor friendly.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Securities and Exchange Board of India (Listing Obl..
17Jan01-17-2024$Tatva Chintan Pharma Chem informs about earnings call Tatva Chintan Pharma Chem in

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that the Earnings Call post announcement of financial results of the Company for the quarter and nine months ended 31st December 2023, is scheduled on Saturday, 20 January 2024 at 04:00 pm (IST). The Call is hosted by ICICI Securities and an invite in this regard is attached. The above information is also being made available on the website of the Company at https://www.tatvachintan.com/.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and D..
08Sep09-08-2023$Tatva Chintan Pharma Chem informs about disclosure Tatva Chintan Pharma Chem in
Tatva Chintan Pharma Chem has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shekhar Rasiklal Somani.

The above information is a part of company’s filings submitted to BSE.

Tatva Chintan Pharma Chem has informed that the Exchange has re..
07Sep09-07-2023$Tatva Chintan Pharma Chem informs about disclosure Tatva Chintan Pharma Chem in
Tatva Chintan Pharma Chem has informed about filing of Report under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 of Ajay Mansukhlal Patel, member of Promoter/ Promoter Group.

The above information is a part of company’s filings submitted to BSE.
Tatva Chintan Pharma Chem has informed about filing of Report u..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit46.51404.649999999999
Gross Profit 65.63 388.309999999999
Operating Profit 135.22603.559999999999
Net Sales 860.694030.44
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Polson (BSE)
 12645.60 (2.05%)
M.Cap ( in Cr)
151.75
GOCL Corporation (BSE)
 453.35 (20.00%)
M.Cap ( in Cr)
2247.37
Polychem (BSE)
 2416.15 (1.66%)
M.Cap ( in Cr)
97.62
SRF (BSE)
 2557.55 (1.38%)
M.Cap ( in Cr)
75812.13
Sree Rayal.Hi-Strent (BSE)
 491.90 (5.55%)
M.Cap ( in Cr)
844.34
Shareholding Pattern More
PROMOTERS 72.02 %
MUTUAL FUNDS/UTI 13.05 %
NON-INSTITUTION 10.71 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes